Evidence map›Paper›PMID 40839151›Full record

ReviewJournal of echocardiography2025

Artificial intelligence in echocardiography: current applications and future perspectives.

Akira Sakamoto, Tomohiro Kaneko, Eiichiro Sato, Wataru Fujita, Yutaka Nakamura, Noriko Yokotsuka, Nobuyuki Kagiyama

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of echocardiography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Akira SakamotoDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-0021, Japan.
Tomohiro KanekoDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-0021, Japan.
Eiichiro SatoDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-0021, Japan.
Wataru FujitaDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-0021, Japan.
Yutaka NakamuraDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-0021, Japan.
Noriko YokotsukaClinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
Nobuyuki KagiyamaDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-0021, Japan. kgnb_27_hot@yahoo.co.jp.ORCID http://orcid.org/0000-0002-2305-0049

Funding

Japan Society for the Promotion of Science 23K15111Japan Society for the Promotion of Science 25K19370Japan Society for the Promotion of Science 25K19371
6 · The paper itself

Abstract

Artificial intelligence (AI) is rapidly transforming the field of echocardiography. By leveraging machine learning, particularly deep learning, AI enhances image acquisition, interpretation, and diagnostic accuracy. It addresses long-standing limitations of echocardiography, such as operator dependency and inter-observer variability. AI-enabled systems, ranging from probe guidance to automated quantification tools, have improved image quality and reduced variability in key measurements such as left ventricular ejection fraction (LVEF). Recent studies show that AI can assist in disease classification, detect regional wall motion abnormalities, and predict disease progression with accuracy comparable to expert assessment. Despite these advances, several challenges remain. Concerns regarding data bias, limited generalizability across populations and devices, and the "black-box" nature of many AI models hinder clinical adoption. Ethical issues, including data privacy and unequal access to digital technologies, also require careful attention. Importantly, AI should be viewed not as a replacement for human expertise but as a tool to augment clinical decision-making and improve workflow efficiency. Looking ahead, integrating echocardiographic data with other clinical information through AI could enable earlier diagnosis and better patient management. As technology evolves, AI is expected to reinforce echocardiography's role as a non-invasive, widely available, and highly informative diagnostic modality. Continued research and rigorous validation are essential to ensure the safe, equitable, and effective use of AI in clinical echocardiography.

Indexed as

Deep LearningEchocardiographyGenerative Artificial IntelligenceHeart DiseasesImage Interpretation, Computer-AssistedConfidentialityDisease ProgressionHumansArtificial intelligenceAutomated diagnosisDeep learningEchocardiography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.